AbbVie Inc. Files 8-K on Financials

Ticker: ABBV · Form: 8-K · Filed: 2025-10-31T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, 8-k

Related Tickers: ABBV

TL;DR

AbbVie dropped an 8-K on Oct 31st covering financials. Check it out.

AI Summary

AbbVie Inc. filed an 8-K on October 31, 2025, reporting on its financial condition and results of operations. The filing also includes financial statements and exhibits. AbbVie Inc. is incorporated in Delaware and its fiscal year ends on December 31.

Why It Matters

This filing provides investors with crucial updates on AbbVie's financial performance and condition, which can influence investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any unusual risks or events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on AbbVie Inc.'s Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on October 31, 2025.

In which state is AbbVie Inc. incorporated?

AbbVie Inc. is incorporated in Delaware.

What is AbbVie Inc.'s fiscal year end?

AbbVie Inc.'s fiscal year ends on December 31.

What is the SEC file number for AbbVie Inc.?

The SEC file number for AbbVie Inc. is 001-35565.

From the Filing

0001551152-25-000047.txt : 20251031 0001551152-25-000047.hdr.sgml : 20251031 20251031075143 ACCESSION NUMBER: 0001551152-25-000047 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20251031 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251031 DATE AS OF CHANGE: 20251031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 251437950 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 8-K 1 abbv-20251031.htm 8-K abbv-20251031 0001551152 false 0001551152 2025-10-31 2025-10-31 0001551152 us-gaap:CommonStockMember exch:XNYS 2025-10-31 2025-10-31 0001551152 abbv:Sec0.750SeniorNotesDue2027Member exch:XNYS 2025-10-31 2025-10-31 0001551152 abbv:Sec2.125SeniorNotesdue2028Member exch:XNYS 2025-10-31 2025-10-31 0001551152 abbv:Sec2625SeniorNotesDue2028Member exch:XNYS 2025-10-31 2025-10-31 0001551152 abbv:Sec2125SeniorNotesDue2029Member exch:XNYS 2025-10-31 2025-10-31 0001551152 abbv:Sec1.250SeniorNotesdue2031Member exch:XNYS 2025-10-31 2025-10-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  _____________________________________________________ FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): October 31, 2025   ABBVIE INC. (Exact name of registrant as specified in its charter) Delaware   001-35565   32-0375147 (State or other Jurisdiction   (Commission File Number)   (IRS Employer of Incorporation)       Identification No.)  _____________________________________________________ 1 North Waukegan Road North Chicago ,  Illinois 60064-6400 (Address of principal executive offices)(Zip Code)   Registrant’s telephone number, including area code:  ( 847 ) 932-7900   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐                       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐                       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐                       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐                       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.01 Par Value   ABBV   New York Stock Exchange NYSE Texas 0.750% Senior Notes due 2027 ABBV27 New York Stock Exchange 2.125% Senior Notes due 2028 ABBV28 New York Stock Exchange 2.625% Senior Notes due 2028 ABBV28B New York Stock Exchange 2.125% Senior Notes due 2029 ABBV29 New

View on Read The Filing